Josep Tabernero

113PUBLICATIONS
835CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersMedical infection agents (incl. prions)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (113)

|Jul 29, 2026
Rechallenge With Anti-Human Epidermal Growth Factor Receptor 2 Therapy Guided by Liquid Biopsy in HER2-Amplified Metastatic Colorectal Cancer.

|Jul 13, 2026
Application of a translational research platform to unveil efficacy signals and mechanisms of resistance of FGFR inhibitors in multiple FGFR-altered solid tumors.

|May 04, 2026
Genomic Landscape, Targeted Therapies, and Mechanisms of Resistance in Molecularly Selected Metastatic Colorectal Cancer Patients.

|Apr 21, 2026
Epigenetic fingerprints link early-onset colon and rectal cancer to pesticide exposure.

|Jan 09, 2026
Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority Trial.

Timothy Iveson, Mark P Saunders, Caroline Kelly

|Dec 29, 2025
Erdafitinib in Patients with FGFR-Altered Advanced or Metastatic Cholangiocarcinoma.

Shubham Pant, Joon Oh Park, Wu-Chou Su

Pageof 19

Frequent Collaborators

17 joint publications

Paulo Nuciforo

13 joint publications

Elena Elez

12 joint publications

Eric Van Cutsem

12 joint publications

Javier Ros